Passage Bio Inc (PASG) — Financial Flexibility Index
Passage Bio Inc (PASG) has a Financial Flexibility Index of -0.53x as of March 2026. Free cash flow of $-12.99 Million (operating CF $-12.99 Million minus capex $0.00) represents -1% of total liabilities ($24.71 Million). Check tangible equity quality of Passage Bio Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Passage Bio Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Passage Bio Inc across 8 annual periods. For the full cash flow conversion analysis, see PASG operating cash flow.
Annual Financial Flexibility Index for Passage Bio Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Passage Bio Inc. Explore PASG operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.72x | $-31.51 Million | $-31.51 Million | $43.53 Million | ▲ +37.8% |
| 2024 | -1.16x | $-47.92 Million | $-47.96 Million | $41.15 Million | ▲ +41.5% |
| 2023 | -1.99x | $-78.12 Million | $-78.26 Million | $39.26 Million | ▲ +25.7% |
| 2022 | -2.68x | $-112.94 Million | $-118.21 Million | $42.18 Million | ▲ +3.7% |
| 2021 | -2.78x | $-101.24 Million | $-126.88 Million | $36.42 Million | ▲ +17.9% |
| 2020 | -3.39x | $-78.87 Million | $-80.52 Million | $23.29 Million | ▲ +62.2% |
| 2019 | -8.97x | $-38.20 Million | $-39.90 Million | $4.26 Million | ▼ -2453.3% |
| 2018 | -0.35x | $-16.02 Million | $-18.57 Million | $45.63 Million | — |